COVID-19 Impact on Global Influenza Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 93 pages | ID: CC031909D038EN
QYResearch

Abstracts

This report focuses on the global Influenza Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Influenza Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbott Laboratories
• Astrazeneca PLC
• Biocryst Pharmaceuticals, Inc.
• Chiron Corporation
• CSL Limited
• Daiichi Sankyo Co., Ltd.
• Glaxosmithkline PLC
• Mitsubishi Tanabe Pharma Corporation
• Nanotherapeutics Inc.
• Protein Sciences Corporation
• Roche Holding AG
• Sanofi SA
• Shionogi & Co., Ltd.
• Sinovac Biotech Ltd.

Market segment by Type, the product can be split into

• Vaccines
• Drugs

Market segment by Application, split into

• Hospitals
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Influenza Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Influenza Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Influenza Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Influenza Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Influenza Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Vaccines
  1.4.3 Drugs
1.5 Market by Application
  1.5.1 Global Influenza Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Influenza Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Influenza Therapeutics Industry
    1.6.1.1 Influenza Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Influenza Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Influenza Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Influenza Therapeutics Market Perspective (2015-2026)
2.2 Influenza Therapeutics Growth Trends by Regions
  2.2.1 Influenza Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Influenza Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Influenza Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Influenza Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Influenza Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Influenza Therapeutics Players by Market Size
  3.1.1 Global Top Influenza Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Influenza Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Influenza Therapeutics Market Concentration Ratio
  3.2.1 Global Influenza Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Influenza Therapeutics Revenue in 2019
3.3 Influenza Therapeutics Key Players Head office and Area Served
3.4 Key Players Influenza Therapeutics Product Solution and Service
3.5 Date of Enter into Influenza Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Influenza Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Influenza Therapeutics Forecasted Market Size by Type (2021-2026)

5 INFLUENZA THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Influenza Therapeutics Market Size by Application (2015-2020)
5.2 Global Influenza Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Influenza Therapeutics Market Size (2015-2020)
6.2 Influenza Therapeutics Key Players in North America (2019-2020)
6.3 North America Influenza Therapeutics Market Size by Type (2015-2020)
6.4 North America Influenza Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Influenza Therapeutics Market Size (2015-2020)
7.2 Influenza Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Influenza Therapeutics Market Size by Type (2015-2020)
7.4 Europe Influenza Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Influenza Therapeutics Market Size (2015-2020)
8.2 Influenza Therapeutics Key Players in China (2019-2020)
8.3 China Influenza Therapeutics Market Size by Type (2015-2020)
8.4 China Influenza Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Influenza Therapeutics Market Size (2015-2020)
9.2 Influenza Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Influenza Therapeutics Market Size by Type (2015-2020)
9.4 Japan Influenza Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Influenza Therapeutics Market Size (2015-2020)
10.2 Influenza Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Influenza Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Influenza Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Influenza Therapeutics Market Size (2015-2020)
11.2 Influenza Therapeutics Key Players in India (2019-2020)
11.3 India Influenza Therapeutics Market Size by Type (2015-2020)
11.4 India Influenza Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Influenza Therapeutics Market Size (2015-2020)
12.2 Influenza Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Influenza Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Influenza Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Details
  13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.1.3 Abbott Laboratories Influenza Therapeutics Introduction
  13.1.4 Abbott Laboratories Revenue in Influenza Therapeutics Business (2015-2020))
  13.1.5 Abbott Laboratories Recent Development
13.2 Astrazeneca PLC
  13.2.1 Astrazeneca PLC Company Details
  13.2.2 Astrazeneca PLC Business Overview and Its Total Revenue
  13.2.3 Astrazeneca PLC Influenza Therapeutics Introduction
  13.2.4 Astrazeneca PLC Revenue in Influenza Therapeutics Business (2015-2020)
  13.2.5 Astrazeneca PLC Recent Development
13.3 Biocryst Pharmaceuticals, Inc.
  13.3.1 Biocryst Pharmaceuticals, Inc. Company Details
  13.3.2 Biocryst Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Introduction
  13.3.4 Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2015-2020)
  13.3.5 Biocryst Pharmaceuticals, Inc. Recent Development
13.4 Chiron Corporation
  13.4.1 Chiron Corporation Company Details
  13.4.2 Chiron Corporation Business Overview and Its Total Revenue
  13.4.3 Chiron Corporation Influenza Therapeutics Introduction
  13.4.4 Chiron Corporation Revenue in Influenza Therapeutics Business (2015-2020)
  13.4.5 Chiron Corporation Recent Development
13.5 CSL Limited
  13.5.1 CSL Limited Company Details
  13.5.2 CSL Limited Business Overview and Its Total Revenue
  13.5.3 CSL Limited Influenza Therapeutics Introduction
  13.5.4 CSL Limited Revenue in Influenza Therapeutics Business (2015-2020)
  13.5.5 CSL Limited Recent Development
13.6 Daiichi Sankyo Co., Ltd.
  13.6.1 Daiichi Sankyo Co., Ltd. Company Details
  13.6.2 Daiichi Sankyo Co., Ltd. Business Overview and Its Total Revenue
  13.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Introduction
  13.6.4 Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
  13.6.5 Daiichi Sankyo Co., Ltd. Recent Development
13.7 Glaxosmithkline PLC
  13.7.1 Glaxosmithkline PLC Company Details
  13.7.2 Glaxosmithkline PLC Business Overview and Its Total Revenue
  13.7.3 Glaxosmithkline PLC Influenza Therapeutics Introduction
  13.7.4 Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2015-2020)
  13.7.5 Glaxosmithkline PLC Recent Development
13.8 Mitsubishi Tanabe Pharma Corporation
  13.8.1 Mitsubishi Tanabe Pharma Corporation Company Details
  13.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview and Its Total Revenue
  13.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Introduction
  13.8.4 Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2015-2020)
  13.8.5 Mitsubishi Tanabe Pharma Corporation Recent Development
13.9 Nanotherapeutics Inc.
  13.9.1 Nanotherapeutics Inc. Company Details
  13.9.2 Nanotherapeutics Inc. Business Overview and Its Total Revenue
  13.9.3 Nanotherapeutics Inc. Influenza Therapeutics Introduction
  13.9.4 Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2015-2020)
  13.9.5 Nanotherapeutics Inc. Recent Development
13.10 Protein Sciences Corporation
  13.10.1 Protein Sciences Corporation Company Details
  13.10.2 Protein Sciences Corporation Business Overview and Its Total Revenue
  13.10.3 Protein Sciences Corporation Influenza Therapeutics Introduction
  13.10.4 Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2015-2020)
  13.10.5 Protein Sciences Corporation Recent Development
13.11 Roche Holding AG
  10.11.1 Roche Holding AG Company Details
  10.11.2 Roche Holding AG Business Overview and Its Total Revenue
  10.11.3 Roche Holding AG Influenza Therapeutics Introduction
  10.11.4 Roche Holding AG Revenue in Influenza Therapeutics Business (2015-2020)
  10.11.5 Roche Holding AG Recent Development
13.12 Sanofi SA
  10.12.1 Sanofi SA Company Details
  10.12.2 Sanofi SA Business Overview and Its Total Revenue
  10.12.3 Sanofi SA Influenza Therapeutics Introduction
  10.12.4 Sanofi SA Revenue in Influenza Therapeutics Business (2015-2020)
  10.12.5 Sanofi SA Recent Development
13.13 Shionogi & Co., Ltd.
  10.13.1 Shionogi & Co., Ltd. Company Details
  10.13.2 Shionogi & Co., Ltd. Business Overview and Its Total Revenue
  10.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Introduction
  10.13.4 Shionogi & Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
  10.13.5 Shionogi & Co., Ltd. Recent Development
13.14 Sinovac Biotech Ltd.
  10.14.1 Sinovac Biotech Ltd. Company Details
  10.14.2 Sinovac Biotech Ltd. Business Overview and Its Total Revenue
  10.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Introduction
  10.14.4 Sinovac Biotech Ltd. Revenue in Influenza Therapeutics Business (2015-2020)
  10.14.5 Sinovac Biotech Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Influenza Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Influenza Therapeutics Revenue
Table 3. Ranking of Global Top Influenza Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Influenza Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Vaccines
Table 6. Key Players of Drugs
Table 7. COVID-19 Impact Global Market: (Four Influenza Therapeutics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Influenza Therapeutics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Influenza Therapeutics Players to Combat Covid-19 Impact
Table 12. Global Influenza Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Influenza Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Influenza Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Influenza Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Influenza Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Influenza Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Influenza Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Influenza Therapeutics Players
Table 23. Global Influenza Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Influenza Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Influenza Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Therapeutics as of 2019)
Table 26. Global Influenza Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Influenza Therapeutics Product Solution and Service
Table 29. Date of Enter into Influenza Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Influenza Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Influenza Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Influenza Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Influenza Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Influenza Therapeutics Market Share (2019-2020)
Table 39. North America Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Influenza Therapeutics Market Share by Type (2015-2020)
Table 41. North America Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Influenza Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Influenza Therapeutics Market Share (2019-2020)
Table 45. Europe Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Influenza Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Influenza Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Influenza Therapeutics Market Share (2019-2020)
Table 51. China Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Influenza Therapeutics Market Share by Type (2015-2020)
Table 53. China Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Influenza Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Influenza Therapeutics Market Share (2019-2020)
Table 57. Japan Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Influenza Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Influenza Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Influenza Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Influenza Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Influenza Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Influenza Therapeutics Market Share (2019-2020)
Table 69. India Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Influenza Therapeutics Market Share by Type (2015-2020)
Table 71. India Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Influenza Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Influenza Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Influenza Therapeutics Market Share (2019-2020)
Table 75. Central & South America Influenza Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Influenza Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Influenza Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Influenza Therapeutics Market Share by Application (2015-2020)
Table 79. Abbott Laboratories Company Details
Table 80. Abbott Laboratories Business Overview
Table 81. Abbott Laboratories Product
Table 82. Abbott Laboratories Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 83. Abbott Laboratories Recent Development
Table 84. Astrazeneca PLC Company Details
Table 85. Astrazeneca PLC Business Overview
Table 86. Astrazeneca PLC Product
Table 87. Astrazeneca PLC Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 88. Astrazeneca PLC Recent Development
Table 89. Biocryst Pharmaceuticals, Inc. Company Details
Table 90. Biocryst Pharmaceuticals, Inc. Business Overview
Table 91. Biocryst Pharmaceuticals, Inc. Product
Table 92. Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 93. Biocryst Pharmaceuticals, Inc. Recent Development
Table 94. Chiron Corporation Company Details
Table 95. Chiron Corporation Business Overview
Table 96. Chiron Corporation Product
Table 97. Chiron Corporation Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 98. Chiron Corporation Recent Development
Table 99. CSL Limited Company Details
Table 100. CSL Limited Business Overview
Table 101. CSL Limited Product
Table 102. CSL Limited Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 103. CSL Limited Recent Development
Table 104. Daiichi Sankyo Co., Ltd. Company Details
Table 105. Daiichi Sankyo Co., Ltd. Business Overview
Table 106. Daiichi Sankyo Co., Ltd. Product
Table 107. Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 108. Daiichi Sankyo Co., Ltd. Recent Development
Table 109. Glaxosmithkline PLC Company Details
Table 110. Glaxosmithkline PLC Business Overview
Table 111. Glaxosmithkline PLC Product
Table 112. Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 113. Glaxosmithkline PLC Recent Development
Table 114. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 115. Mitsubishi Tanabe Pharma Corporation Product
Table 116. Mitsubishi Tanabe Pharma Corporation Company Details
Table 117. Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 118. Mitsubishi Tanabe Pharma Corporation Recent Development
Table 119. Nanotherapeutics Inc. Company Details
Table 120. Nanotherapeutics Inc. Business Overview
Table 121. Nanotherapeutics Inc. Product
Table 122. Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 123. Nanotherapeutics Inc. Recent Development
Table 124. Protein Sciences Corporation Company Details
Table 125. Protein Sciences Corporation Business Overview
Table 126. Protein Sciences Corporation Product
Table 127. Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 128. Protein Sciences Corporation Recent Development
Table 129. Roche Holding AG Company Details
Table 130. Roche Holding AG Business Overview
Table 131. Roche Holding AG Product
Table 132. Roche Holding AG Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 133. Roche Holding AG Recent Development
Table 134. Sanofi SA Company Details
Table 135. Sanofi SA Business Overview
Table 136. Sanofi SA Product
Table 137. Sanofi SA Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 138. Sanofi SA Recent Development
Table 139. Shionogi & Co., Ltd. Company Details
Table 140. Shionogi & Co., Ltd. Business Overview
Table 141. Shionogi & Co., Ltd. Product
Table 142. Shionogi & Co., Ltd. Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 143. Shionogi & Co., Ltd. Recent Development
Table 144. Sinovac Biotech Ltd. Company Details
Table 145. Sinovac Biotech Ltd. Business Overview
Table 146. Sinovac Biotech Ltd. Product
Table 147. Sinovac Biotech Ltd. Revenue in Influenza Therapeutics Business (2015-2020) (Million US$)
Table 148. Sinovac Biotech Ltd. Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Influenza Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Vaccines Features
Figure 3. Drugs Features
Figure 4. Global Influenza Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Influenza Therapeutics Report Years Considered
Figure 9. Global Influenza Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Influenza Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Influenza Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Influenza Therapeutics Market Share by Players in 2019
Figure 14. Global Top Influenza Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Influenza Therapeutics Revenue in 2019
Figure 16. North America Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Influenza Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abbott Laboratories Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 25. Astrazeneca PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Astrazeneca PLC Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 27. Biocryst Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Biocryst Pharmaceuticals, Inc. Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 29. Chiron Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Chiron Corporation Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 31. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. CSL Limited Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 33. Daiichi Sankyo Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Daiichi Sankyo Co., Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 35. Glaxosmithkline PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Glaxosmithkline PLC Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 37. Mitsubishi Tanabe Pharma Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 39. Nanotherapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Nanotherapeutics Inc. Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 41. Protein Sciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Protein Sciences Corporation Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 43. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Roche Holding AG Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 45. Sanofi SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Sanofi SA Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 47. Shionogi & Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Shionogi & Co., Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 49. Sinovac Biotech Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sinovac Biotech Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed